Pedia-Lax Chewable Tablets Interactions
There are 414 drugs known to interact with Pedia-Lax Chewable Tablets (magnesium hydroxide), along with 3 disease interactions. Of the total drug interactions, 12 are major, 328 are moderate, and 74 are minor.
- View all 414 medications that may interact with Pedia-Lax Chewable Tablets
- View Pedia-Lax Chewable Tablets disease interactions (3)
Most frequently checked interactions
View interaction reports for Pedia-Lax Chewable Tablets (magnesium hydroxide) and the medicines listed below.
- albuterol
- budesonide
- Calmoseptine (menthol/zinc oxide topical)
- Carafate (sucralfate)
- cyproheptadine
- Diastat (diazepam)
- Eczemin (pramoxine topical)
- erythromycin
- Flonase (fluticasone nasal)
- Florastor (saccharomyces boulardii lyo)
- fluocinonide topical
- guaifenesin
- hydrocortisone
- ibuprofen
- Ipratropium Inhalation Aerosol (ipratropium)
- levetiracetam
- MiraLAX (polyethylene glycol 3350)
- multivitamin
- mupirocin topical
- NanoVM Adult (multivitamin with minerals)
- nystatin
- Omega-3 (omega-3 polyunsaturated fatty acids)
- Onfi (clobazam)
- Probiotic Formula (bifidobacterium infantis / lactobacillus acidophilus)
- ranitidine
- Saline Mist (sodium chloride nasal)
- simethicone
- Transderm-Scop (scopolamine)
- Tylenol (acetaminophen)
- Zofran (ondansetron)
Pedia-Lax Chewable Tablets disease interactions
There are 3 disease interactions with Pedia-Lax Chewable Tablets (magnesium hydroxide) which include:
Report options
QR code containing a link to this page
More about Pedia-Lax Chewable Tablets (magnesium hydroxide)
- Pedia-Lax Chewable Tablets consumer information
- Compare alternatives
- Pricing & coupons
- Latest FDA alerts (2)
- Side effects
- Dosage information
- During pregnancy
- Drug class: antacids
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.